71 related articles for article (PubMed ID: 7909417)
1. Difference in cytotoxicity of paclitaxel against neoplastic and normal cells.
Matsuoka H; Furusawa M; Tomoda H; Seo Y
Anticancer Res; 1994; 14(1A):163-7. PubMed ID: 7909417
[TBL] [Abstract][Full Text] [Related]
2. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index.
Ozcan Arican G
Cancer Chemother Pharmacol; 2005 Aug; 56(2):221-9. PubMed ID: 15838658
[TBL] [Abstract][Full Text] [Related]
4. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
Cordes N; Plasswilm L
Anticancer Res; 1998; 18(3A):1851-7. PubMed ID: 9673415
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
[TBL] [Abstract][Full Text] [Related]
6. Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase.
Lin HL; Chang YF; Liu TY; Wu CW; Chi CW
Anticancer Res; 1998; 18(5A):3443-9. PubMed ID: 9858922
[TBL] [Abstract][Full Text] [Related]
7. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
Liebmann JE; Fisher J; Teague D; Cook JA
Oncol Res; 1994; 6(1):25-31. PubMed ID: 7919549
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
9. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
10. Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol).
Liebmann J; Cook JA; Teague D; Fisher J; Mitchell JB
Anticancer Drugs; 1994 Jun; 5(3):287-92. PubMed ID: 7919452
[TBL] [Abstract][Full Text] [Related]
11. Differential paclitaxel-induced cytotoxicity in rodent and human hepatoma cell lines.
Lui WY; Chang YF; Li LL; Ho LK; Su TL; Chen JY; Liu TY; P'Eng FK; Chi CW
Anticancer Res; 1998; 18(5A):3339-45. PubMed ID: 9858906
[TBL] [Abstract][Full Text] [Related]
12. Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.
Michalakis J; Georgatos SD; de Bree E; Polioudaki H; Romanos J; Georgoulias V; Tsiftsis DD; Theodoropoulos PA
Ann Surg Oncol; 2007 Mar; 14(3):1220-8. PubMed ID: 17206477
[TBL] [Abstract][Full Text] [Related]
13. The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.
Toiyama Y; Inoue Y; Hiro J; Ojima E; Watanabe H; Narita Y; Hosono A; Miki C; Kusunoki M
Cancer Chemother Pharmacol; 2007 May; 59(6):733-42. PubMed ID: 16957932
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
15. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
16. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
[TBL] [Abstract][Full Text] [Related]
18. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
19. Resistance to paclitaxel is proportional to cellular total antioxidant capacity.
Ramanathan B; Jan KY; Chen CH; Hour TC; Yu HJ; Pu YS
Cancer Res; 2005 Sep; 65(18):8455-60. PubMed ID: 16166325
[TBL] [Abstract][Full Text] [Related]
20. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
Pratt MA; Niu MY; Renart LI
Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
